Pembrolizumab and Stereotactic Radiosurgery for Melanoma or Non-Small Cell Lung Cancer Brain Metastases

Clinical trial NCT02858869 · COMPLETED

Trial details

NCT number: NCT02858869
Sponsor: Emory University
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Metastatic Malignant Neoplasm in the Brain Metastatic Melanoma Mucosal Melanoma Ocular Melanoma Stage IV Non-Small Cell Lung Cancer Stage IV Skin Melanoma Melanoma of Unknown Primary

Start date: 2016-10-04
Primary completion: 2020-11-19
Enrollment: 25

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.